Stenotrophomonas maltophilia (S. maltophilia) is a nonfermentative bacterium, which is naturally resistant against a panel of commonly-used antibiotics. It is frequently isolated from humans with chronic respiratory disease, e.g. cystic fi brosis or chronic obstructive pulmonary disease. In veterinary medicine S. maltophilia is perceived to be a mere coloniser. We herewith report 7 strains of S. maltophilia isolated from animals, of which 5 strains were harvested from 3 horses, a dog and a cat with chronic respiratory disease. The dog isolate showed resistance to trimethoprim / sulphamethoxazole, which was confi rmed by detection of the sul 1 gene. Analysis with pulsed fi eld gel electrophoresis revealed that 2 horses, which were boarded in the same clinic but two years apart, harboured the same strain of S. maltophilia. This is indicative of a hospital acquired colonisation / infection, which contradicts involvement in the pre-existing chronic disease.
Introduction
Stenotrophomonas maltophilia (S. maltophilia) is a gram-negative, oxidase-negative rod, which was previously known as Pseudomonas maltophilia and Xanthomonas maltophilia. The bacterium is ubiquitous in nature, prevailing in soil, plant material, water and sewage (Denton and Kerr, 1998a) . In animals it was isolated, e.g. from squirrel faeces (Cloud-Hansen et al., 2007) , porcine semen (Althouse et al., 2005) , oral fl ora of snakes (Hejnar et al., 2007) and fl eece rot in sheep (MacDiarmid and Burrell, 1986) . Despite earlier doubts about its pathogenicity, it is now established as an important emerging nosocomial pathogen in human medicine and is no longer regarded as a harmless coloniser. In patients that are immunocomprimised or suffering from chronic disease, e.g. cystic fi brosis (CF) or chronic obstructive pulmonary disease (COPD), infection with S. maltophilia contributes to higher fatalities (Denton and Kerr, 1998a) . Unlike other nosocomial pathogens, outbreaks with S. maltophilia are rarely due to single emerging strains. Rather, different strains from sources like water taps, water dispensers, inhalation therapy equipment, blood-sampling tubes or hands of medical staff may be isolated in parallel from different patients (Denton and Kerr, 1998a; Denton et al., 1998b; Abbassi et al., 2008) . S. maltophilia is mainly considered as a nosocomial bacterium on the basis that it is naturally resistant to many commonly-used antibiotics.
Species-specifi c S. maltophilia PCR
For confi rmation of biochemical identifi cation, 5 colonies were lysed as described above. Lysates were subjected to a previously described S. maltophilia species-specifi c PCR amplifying a 531 bp product (Whitby et al., 2000) , carried out with the following modifi cations: 3 μl of sample lysate was added to 22 μl of reaction mixture containing 0.2 μM of each Primer (SM1 5'-CAGCCTGCGAAAAG-TA-3'; SM4 5'-TTAAGCTTGCCACGAACAG-3'), 100 μM of each dNTP, 2.5 mM 
Antimicrobial susceptibility testing
All isolates were tested with the automated susceptibility test strips ATB®PSE 5 and ATB®VET strips (BioMérieux), a micro-dilution technique, performed according to the manufacturer's recommendations. Briefl y, the bacteria are grown on TSA, a few colonies are suspended in sterile saline to a turbidity of 0.5 × McFarland, transferred to a semi-solid growth medium, and pipetted into each well of the strip, containing different antibiotics. The strip is then incubated at 37 °C for 18 -24 h and hence read with the automated miniAPI system.
Detection of sul 1 gene by PCR and verifi cation by sequencing
For one PCR reaction for the detection of sul 1 gene the same PCR reaction mixture was used as described above with 20 pmol of each primer SulI-L GTGACGGTGTT-CGGCATTCT and SulI-R TCCGAGAAGGTGATTGCG-CT (Lanz et al., 2003) . The product was sequenced with the same primers, as described by Kuhnert et al. (2002) .
Pulsed Field Gel Electrophoresis (PFGE)
S. maltophilia strains were incubated overnight on TSA at 37 °C. Organisms were analysed according to the "Pseudomonas aeruginosa PFGE protocol" (www.hpa.org.uk). Bacteria were suspended in 1 ml SE Buffer (75 mM NaCl, 25 mM EDTA Na2, sterile fi ltered) to a turbidity of 2.5 McFarland. 350 μl bacterial suspension was carefully mixed with 350 μl 2 % pulsed fi eld certifi ed agarose (BioRad, Reinach, Switzerland) in a waterbath at 56 °C and immediately transferred to the plug moulds. Moulds were allowed to set at 4 °C. Plugs were transferred to sterile glass vials and incubated in 3 ml gram-positive lysis buffer (pH The drug of choice is trimethoprim / sulphamethoxazole, but resistance mediated by sul genes is emerging (Toleman et al., 2007) . Little is known about the occurrence of S. maltophilia in animals with respiratory disease. We herein describe isolates from the routine diagnostic laboratory, which were harvested with routine culture methods. We were interested, whether the fi nding of S. maltophilia in three horses, a dog and a cat with chronic respiratory disease is suggestive of a similar importance as described in human CF or COPD patients and how the fi nding of this bacterium should be interpretated in diagnostic samples.
Animals, Material and Methods

Bacterial strains and culture methods
Bacterial isolates used in this study were derived from routine diagnostic specimens from veterinary patients from 2005 to 2007: Tracheobronchial wash (TBW) from 120 horses, 5 dogs and 4 cats, bronchoalveolar lavage (BAL) from 7 horses, 59 dogs and 29 cats and nasal swabs from 117 horses, 53 dogs and 72 cats. From these, a total of 5 strains were obtained from 3 horses (isolates 1, 2 and 3), one dog (isolate 4) and one cat (isolate 6). Further, isolate 5 was obtained from a wound infection in a dog and isolate 7 from an oral swab of a ball python (Python regius). Isolates 1 (from 2005) and 3 (from 2007) derived from horses from the same clinic. Also, isolates 4 (from 2007) and 5 (from 2005) derived from one practice (Tab. 1). All animals, apart from the snake, had been pre-treated with antibiotics and were presented to the veterinarian because of persisting respiratory disease (case isolates 1, 2, 3, 4, 6) or post operative wound infection (isolate 5). Samples were routinely cultured on various media, but S. maltophilia was always isolated from tryptone soy agar with 5 % sheep blood (TSA; Oxoid, Basel, Switzerland) incubated at 37 °C. S. maltophilia and concomitant fl ora was identifi ed with the API ID system (BioMérieux, Geneva, Switzerland). The type strain S. maltophilia DSM 50170 (ATCC 13637 T ) was obtained from the German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany).
PCR analysis from TBW or BAL samples
For PCR analysis only, TBW or BAL from routine material deriving from 42 horses was additionally tested. Sediments from the samples obtained by centrifugation were lysed in 450 μl lysis buffer containing 0.1 M TrisHCl [pH 8.5], 0.05 % Tween 20, 0.24 mg of proteinase K (Roche, Reinach, Switzerland) per ml and were incubated for 60 min at 60 °C followed by inactivation of the proteinase K for 15 min at 97 °C and subjected to S. maltophilia PCR. Semiquantitative scheme: less than ten bacterial colonies (+/-), ten to 30 colonies: (+), 30 to 100 colonies (++) and more than 100 colonies (+++) per plate was done in 100 μl 1x enzyme buffer at 37 °C overnight. The separation of the DNA fragments was performed in a Chef-Dr® III System (BioRad). The running buffer 0.5 × TBE contained 9 mg/l thiourea (Merck, Darmstadt, Germany). With this 0.5 × TBE buffer, a 1.2 % pulsed fi eld certifi ed agarose gel was made, the digested plugs were loaded and run with Lambda 1 marker (New England BioLabs, Ipswich, MA, USA) under the following conditions: 12 °C, initial start time 1 s, fi nal start time 50 s, gradient 6 V, angle 120 °, run time 30 h. The gel was then stained for 40min in 300ml TBE with 30 μl ethidiumbromide, destained in 300 ml aqua bidest for 1h and analysed in a GelDoc 2000 (BioRad).
7.5; consisting of 6 mM Tris-HCl, 100 mM EDTA Na2, 1 M NaCl, 0.5 % (w/v) Brij 58, 0.2 % (w/v) sodium deoxycholate, 0.5 % lauroyl sarcosine) containing 500 μg/ml lysozyme (Roche) at 37 °C overnight. The gram-positive lysis buffer was hence drawn off and the plugs resuspended in gram-negative lysis buffer (pH: 9.5; consisting of 1 % N-lauroyl sarcosine sodium salt, 500mM EDTA Na 2, sterile fi ltered) containing 500 μg/ml Proteinase K (Roche) and incubated overnight at 56 °C. The gram-negative buffer was removed and the plugs washed thrice in 3 ml TE buffer at 4 °C for 30 min. A 2mm portion of the plugs was incubated in 100μl 1x reaction buffer at 4 °C for 30 min. The reaction buffer was discharged and restriction digestion with 30 U of either SpeI or XbaI (Roche) 
Results
Identifi cation of S. maltophilia with biochemical reactions and PCR
From 244 equine, 117 canine and 105 feline respiratory tract samples fi ve isolates of S. maltophilia were harvested with routine culture methods. All strains biochemically identifi ed as S. maltophilia were subsequently confi rmed with the S. maltophilia species-specifi c PCR, whilst negative controls did not produce a signal. From 42 equine TBW or BAL samples crude lysates of two TBW samples were found to be positive in a S. maltophilia specifi c PCR, where S. maltophilia had not been found in the culture. The two samples derived from horses that were boarded at clinic 1 (Tab. 1).
Antimicrobial susceptibility and detection of sul genes
Antimicrobial susceptibilities are shown in Table 2 . Isolate 4 that originated from BAL from a dog with chronic cough, showed resistance to trimethoprim / sulphamethoxazole. Therefore a specifi c PCR was carried out for the detection of sul 1, which was consequently detected in isolate 4, bearing a sequence identity of 100 %.
Pulsed Field Gel Electrophoresis (PFGE)
Analysis with SpeI showed an identical pattern in strains 1 and 3, while all other strains were unique (Fig. 1 ). The identical strains had been collected two years apart, but were derived from the same horse clinic. For confi rmation new plugs were made and the procedure repeated for all strains with XbaI, yielding the same result (data not shown).
Discussion
Isolation of S. maltophilia is probably underdiagnosed in the routine veterinary diagnostic laboratory, as no selective media that increase the isolation success of S. maltophilia (Kerr et al., 1996a) are used. In highly contaminated samples S. maltophilia may not be retrieved.
In most samples of this study from where S. maltophilia was isolated a variety of other bacteria were growing as well (Tab. 1). Isolation of S. maltophilia in mixed culture is not a rare event, and was long seen as evidence that this bacterium may only be a coloniser without contribution to disease, unless the host is immunocomprimised. However, it is now widely established that isolation of S. maltophilia from normally sterile sites is signifi cant (Denton and Kerr, 1998) . Nonetheless, the signifi cance of S. maltophilia in veterinary routine specimens is not easy to pinpoint. First, it is diffi cult to distinguish infection from colonisation. S. maltophilia was isolated from the upper respiratory tract in horses from oral-tracheal swabs (Mancini et al., 2005) and guttural pouch (DeBiasio, 2003) without association with respiratory disease. Nevertheless, samples from normally sterile sites in the lower respiratory tract should not yield this bacterium. Secondly, S. maltophilia is known to inhibit potentially signifi cant fungi (Kerr, 1996b) , therefore an underlying disease may be missed. Furthermore, it must be noticed that S. maltophilia was shown in vitro to activate infl uenza virus by cleavage of haemagglutinin, a fact that could be of signifi cance in unvaccinated horses (Mancini et al., 2005) . The yield of a pure culture of S. maltophilia from a suture dehiscence in a dog (isolate 5) can be easily interpretated as a secondary wound infection, while the fi nding in the ball python (isolate 7) denotes a part of the normal oral fl ora of snakes (Hejnar et al., 2007) . Contrary, the fi nding of S. maltophilia in horses with chronic coughing (isolates 1, 2 and 3) and in a dog (isolate 4) and a cat (isolate 6) with chronic respiratory disease was intriguing at fi rst sight, and bears similarities to the occurrence of S. maltophilia in human patients with COPD or CF. Risk factors for S. maltophilia colonisation and infections are likely to be similar in veterinary medicine as reported for human cases. S. maltophilia infections benefi t from preceded antibiotic therapy, which in human medicine is often due to imipenem or vancomycin treatment (antibiotics that are not registered for veterinary use in Switzerland), but other antibiotics like cephalosporins, gentamicin or fl uorochinolons, also select for S. maltophilia (Suilen et al., 1999 ). The bacterium is also known to adhere to plastic parts like intravenous catheters, in-halation equipment or bronchoscopes (Denton and Kerr, 1998a; Suilen et al., 1999) . The fi nding of S. maltophilia should therefore always alert the veterinarian concerning the contamination of any equipment used. But unlike other hospitalism-agents where clonal occurrence and the establishment of one strain is the rule (Boerlin et al., 2001 ), S. maltophilia from different patients even in hospital environnements are mostly different strains (Sader et al., 1994) . Outbreaks with clonal occurrence do occur, but rarely (Abbassi et al., 2008) . Analysis of isolates with PFGE may be useful to uncover such an establishment of a particular strain. When we did this, our study strains 1 and 3 that derived from horses that had been boarded in the same clinic, but two years apart, surprisingly yielded the same strain of S. maltophilia (Fig. 1) . The two dog strains (4 and 5) also came from one practice, but were shown to be different (Fig. 1) . Unfortunately, it was not possible to analyse environmental samples from clinic 1 and the precise source remains unknown. Nevertheless it can be deduced that this strain is present in the clinic environment, was acquired in the clinic and was not present in the horses beforehand. This is further supported by the positive PCR testing of horses only from clinic 1. Thus, at second sight, involvement of S. maltophilia in the observed clinical disease is therefore unlikely.
In conclusion, the signifi cance of S. maltophilia is not always clear. Notwithstanding, the isolation, identifi cation and susceptibility testing of this multi-resistant bacterium may be of particular importance in animals with chronic coughing that are companion animals for humans with known chronic respiratory diseases. The fi nding of an isolate with sul 1-mediated resistance to trimethoprim / sulphamethoxazole in a dog may be regarded with caution, although transmission from animals to humans have not been reported to date.
Isolamento della Stenotrophomonas maltophilia dal tratto respiratorio di animali affetti da malattie croniche delle vie respiratorie
Stenotrophomonas maltophilia (S. maltophilia) è un battere non fermentativo che resiste naturalmente a molti antibiotici utilizzati normalmente. Viene spesso isolato negli uomini affetti da malattie croniche delle vie respiratorie come la fi brosi cistica o la malattia polmonare ostruttiva cronica. In medicina veterinaria, l'S. maltophilia, viene considerato come semplice colonizzatore. Qui di seguito facciamo riferimento a 7 ceppi di S. maltophilia isolati da animali di cui 5 sono stati isolati da 3 cavalli, un cane e un gatto affetti da malattie croniche delle vie respiratorie. L'isolato del cane si è dimostrato resistente alla trimethoprim-sulfametossazolo cosa confermata dal ritrovamento del gene sul 1. Le analisi con elettroforesi a campi pulsanti (Pulsed Field Gel) hanno mostrato che lo stesso ceppo era presente in due cavalli che si trovavano a distanza di due anni nella medesima clinica. Questi dimostra una colonizzazione/infezione in ospedale, escludendo una partecipatione dell'agente in questione alla malattia cronica preesistente.
Isolation de Stenotrophomas maltophilia dans le système respiratoire d'animaux souffrant de problèmes respiratoires chroniques.
Stenotrophomas maltophilia est une bactérie non fermentative qui est naturellement résistante face à de nombreux antibiotiques employés de façon routiniè-re. Il est souvent isolé chez des êtres humains souffrant de maladies respiratoires chroniques telle la fi brose cystique ou les maladies obstructives chroniques. En médecine vétérinaire, Stenotrophomas maltophilia est considéré comme un simple opportuniste. Nous rapportons l'isolation de souches de S. maltophilia chez 7 animaux donc 5 provenant de 3 chevaux, 1 d'un chien et 1 d'un chat souffrant tous de maladies respiratoires chroniques. L'isolat du chien était résistant au Trimé-thoprim / Sulfamethoxazol ce qui a été confi rmé par la détection du gène sul 1. Les analyses par électrophorè-ses ont montré que le même germe était présent chez 2 chevaux présentés à 2 ans d'intervalles à la même clinique. Ceci laisse conclure à une infection contractée en milieu hospitalier, ce qui contredit son implication dans la maladie chronique pré-existante.
